ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Portola Pharmaceuticals, Inc.
NEW YORK, May 5, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) and its board of directors concerning the proposed acquisition of the company by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Stockholders will receive $18.00 for each share of Portola Pharmaceuticals stock that they hold. The transaction is valued at approximately $1.4 billion and is expected to close in the third quarter of 2020.
If you are a stockholder of Portola Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/ptla. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at firstname.lastname@example.org, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
Company Codes: NASDAQ-NMS:ALXN, NASDAQ-NMS:PTLA